Literature DB >> 21907265

DJ-1 knock-down impairs astrocyte mitochondrial function.

N J Larsen1, G Ambrosi, S J Mullett, S B Berman, D A Hinkle.   

Abstract

Mitochondrial dysfunction has long been implicated in the pathogenesis of Parkinson's disease (PD). PD brain tissues show evidence for mitochondrial respiratory chain Complex I deficiency. Pharmacological inhibitors of Complex I, such as rotenone, cause experimental parkinsonism. The cytoprotective protein DJ-1, whose deletion is sufficient to cause genetic PD, is also known to have mitochondria-stabilizing properties. We have previously shown that DJ-1 is over-expressed in PD astrocytes, and that DJ-1 deficiency impairs the capacity of astrocytes to protect co-cultured neurons against rotenone. Since DJ-1 modulated, astrocyte-mediated neuroprotection against rotenone may depend upon proper astrocytic mitochondrial functioning, we hypothesized that DJ-1 deficiency would impair astrocyte mitochondrial motility, fission/fusion dynamics, membrane potential maintenance, and respiration, both at baseline and as an enhancement of rotenone-induced mitochondrial dysfunction. In astrocyte-enriched cultures, we observed that DJ-1 knock-down reduced mitochondrial motility primarily in the cellular processes of both untreated and rotenone treated cells. In these same cultures, DJ-1 knock-down did not appreciably affect mitochondrial fission, fusion, or respiration, but did enhance rotenone-induced reductions in the mitochondrial membrane potential. In neuron-astrocyte co-cultures, astrocytic DJ-1 knock-down reduced astrocyte process mitochondrial motility in untreated cells, but this effect was not maintained in the presence of rotenone. In the same co-cultures, astrocytic DJ-1 knock-down significantly reduced mitochondrial fusion in the astrocyte cell bodies, but not the processes, under the same conditions of rotenone treatment in which DJ-1 deficiency is known to impair astrocyte-mediated neuroprotection. Our studies therefore demonstrated the following new findings: (i) DJ-1 deficiency can impair astrocyte mitochondrial physiology at multiple levels, (ii) astrocyte mitochondrial dynamics vary with sub-cellular region, and (iii) the physical presence of neurons can affect astrocyte mitochondrial behavior.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21907265      PMCID: PMC3490195          DOI: 10.1016/j.neuroscience.2011.08.016

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  76 in total

Review 1.  Mitochondrial morphology and dynamics in yeast and multicellular eukaryotes.

Authors:  Koji Okamoto; Janet M Shaw
Journal:  Annu Rev Genet       Date:  2005       Impact factor: 16.830

2.  Pesticide exposure and risk for Parkinson's disease.

Authors:  Alberto Ascherio; Honglei Chen; Marc G Weisskopf; Eilis O'Reilly; Marjorie L McCullough; Eugenia E Calle; Michael A Schwarzschild; Michael J Thun
Journal:  Ann Neurol       Date:  2006-08       Impact factor: 10.422

3.  Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1.

Authors:  Guido Krebiehl; Sabine Ruckerbauer; Lena F Burbulla; Nicole Kieper; Brigitte Maurer; Jens Waak; Hartwig Wolburg; Zemfira Gizatullina; Frank N Gellerich; Dirk Woitalla; Olaf Riess; Philipp J Kahle; Tassula Proikas-Cezanne; Rejko Krüger
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

4.  Astrocytic complexity distinguishes the human brain.

Authors:  Nancy Ann Oberheim; Xiaohai Wang; Steven Goldman; Maiken Nedergaard
Journal:  Trends Neurosci       Date:  2006-08-30       Impact factor: 13.837

5.  The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis.

Authors:  Jin Xu; Nan Zhong; Haoyong Wang; Joshua E Elias; Christina Y Kim; Irina Woldman; Christian Pifl; Steven P Gygi; Changiz Geula; Bruce A Yankner
Journal:  Hum Mol Genet       Date:  2005-03-24       Impact factor: 6.150

6.  Mitochondrial membrane potential monitored by JC-1 dye.

Authors:  M Reers; S T Smiley; C Mottola-Hartshorn; A Chen; M Lin; L B Chen
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

7.  Integrating multiple aspects of mitochondrial dynamics in neurons: age-related differences and dynamic changes in a chronic rotenone model.

Authors:  Beth Arnold; Steven J Cassady; Victor S VanLaar; Sarah B Berman
Journal:  Neurobiol Dis       Date:  2010-09-17       Impact factor: 5.996

8.  Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration.

Authors:  Khaled Radad; Wolf-Dieter Rausch; Gabriele Gille
Journal:  Neurochem Int       Date:  2006-03-31       Impact factor: 3.921

9.  Rotenone-induced toxicity is mediated by Rho-GTPases in hippocampal neurons.

Authors:  Monica Sanchez; Laura Gastaldi; Monica Remedi; Alfredo Cáceres; Carlos Landa
Journal:  Toxicol Sci       Date:  2008-05-13       Impact factor: 4.849

10.  Bcl-x L increases mitochondrial fission, fusion, and biomass in neurons.

Authors:  Sarah B Berman; Ying-bei Chen; Bing Qi; J Michael McCaffery; Edmund B Rucker; Sandra Goebbels; Klaus-Armin Nave; Beth A Arnold; Elizabeth A Jonas; Fernando J Pineda; J Marie Hardwick
Journal:  J Cell Biol       Date:  2009-03-02       Impact factor: 10.539

View more
  40 in total

Review 1.  The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease.

Authors:  Victor S Van Laar; Sarah B Berman
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

Review 2.  Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms.

Authors:  Arthi Kanthasamy; Huajun Jin; Adhithiya Charli; Anantharam Vellareddy; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

3.  Use of cysteine-reactive cross-linkers to probe conformational flexibility of human DJ-1 demonstrates that Glu18 mutations are dimers.

Authors:  Janani Prahlad; David N Hauser; Nicole M Milkovic; Mark R Cookson; Mark A Wilson
Journal:  J Neurochem       Date:  2014-06-19       Impact factor: 5.372

Review 4.  Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.

Authors:  Annadurai Anandhan; Maria S Jacome; Shulei Lei; Pablo Hernandez-Franco; Aglaia Pappa; Mihalis I Panayiotidis; Robert Powers; Rodrigo Franco
Journal:  Brain Res Bull       Date:  2017-03-21       Impact factor: 4.077

Review 5.  The role of astrocyte mitochondria in differential regional susceptibility to environmental neurotoxicants: tools for understanding neurodegeneration.

Authors:  Laura L Kubik; Martin A Philbert
Journal:  Toxicol Sci       Date:  2015-03       Impact factor: 4.849

Review 6.  Microglia and astrocyte dysfunction in parkinson's disease.

Authors:  Tae-In Kam; Jared T Hinkle; Ted M Dawson; Valina L Dawson
Journal:  Neurobiol Dis       Date:  2020-07-28       Impact factor: 5.996

7.  Astrocytic dynamin-like protein 1 regulates neuronal protection against excitotoxicity in Parkinson disease.

Authors:  Jake G Hoekstra; Travis J Cook; Tessandra Stewart; Hayley Mattison; Max T Dreisbach; Zachary S Hoffer; Jing Zhang
Journal:  Am J Pathol       Date:  2014-12-04       Impact factor: 4.307

Review 8.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

Review 9.  ATP synthase c-subunit ring as the channel of mitochondrial permeability transition: Regulator of metabolism in development and degeneration.

Authors:  Nelli Mnatsakanyan; Elizabeth Ann Jonas
Journal:  J Mol Cell Cardiol       Date:  2020-05-24       Impact factor: 5.000

10.  Knocking out DJ-1 attenuates astrocytes neuroprotection against 6-hydroxydopamine toxicity.

Authors:  Nirit Lev; Yael Barhum; Tali Ben-Zur; Eldad Melamed; Israel Steiner; Daniel Offen
Journal:  J Mol Neurosci       Date:  2013-03-28       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.